Your browser doesn't support javascript.
loading
GDF15 and Growth Control.
Emmerson, Paul J; Duffin, Kevin L; Chintharlapalli, Sudhakar; Wu, Xinle.
Affiliation
  • Emmerson PJ; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, United States.
  • Duffin KL; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, United States.
  • Chintharlapalli S; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, United States.
  • Wu X; Lilly China Innovation and Partnerships, Shanghai, China.
Front Physiol ; 9: 1712, 2018.
Article in En | MEDLINE | ID: mdl-30542297
ABSTRACT
Growth/differentiation factor-15 (GDF-15) is a distant member of the transforming growth factor ß (TGF-ß) superfamily and is widely expressed in multiple mammalian tissues. Its expression is highly regulated and is often induced in response to conditions associated with cellular stress. GDF15 serum levels have a strong association with many diseases, including inflammation, cancer, cardiovascular diseases, and obesity, and potentially serve as reliable predictor of disease progression. A functional role for GDF15 has been suggested in cancer, cardiovascular disease, kidney disease and metabolic disease. However, the knowledge of its pathophysiological function at the molecular level is still limited and requires more investigation. Recent identification of the endogenous receptor for GDF15 may provide additional insight in to its' molecular mechanisms and relationship to disease states.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Physiol Year: 2018 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Physiol Year: 2018 Document type: Article Affiliation country: United States
...